|
CH621479A5
(US06272168-20010807-M00014.png)
*
|
1977-08-05 |
1981-02-13 |
Battelle Memorial Institute |
|
|
IT1110989B
(it)
*
|
1979-01-19 |
1986-01-13 |
Erba Farmitalia |
Forme farmaceutiche costitutite da liposomi e procedimenti relativi
|
|
FR2416008A1
(fr)
*
|
1978-02-02 |
1979-08-31 |
Oreal |
Lyophilisats de liposomes
|
|
JPS55118415A
(en)
*
|
1979-02-28 |
1980-09-11 |
Pii Papahadojiyopo Dometoriosu |
Method of encapsulating biologically active substance in lipoid cell
|
|
DE2914789A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Injizierbare arzneimittel mit entzuendungshemmender wirkung
|
|
DE2914788A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
|
|
JPS55153713A
(en)
*
|
1979-05-02 |
1980-11-29 |
Kureha Chem Ind Co Ltd |
Pharmaceutical preparation of ribosome containing active substance
|
|
CA1173360A
(en)
*
|
1979-06-22 |
1984-08-28 |
Jurg Schrank |
Pharmaceutical preparations
|
|
US4310505A
(en)
*
|
1979-11-08 |
1982-01-12 |
California Institute Of Technology |
Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
|
|
HU184141B
(en)
*
|
1979-12-27 |
1984-07-30 |
Human Oltoanyagtermelo |
Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
|
|
JPS5775916A
(en)
*
|
1980-10-29 |
1982-05-12 |
Nippon Chemiphar Co Ltd |
Coenzyme q pharmaceutical and its preparation
|
|
JPS57146710A
(en)
*
|
1981-03-07 |
1982-09-10 |
Kunio Yagi |
Blood brain-barrier permeating ribosome-like microcapsule
|
|
US4397846A
(en)
*
|
1981-05-15 |
1983-08-09 |
Murray Weiner |
Storage-stable lipid vesicles and method of preparation
|
|
JPS58128318A
(ja)
*
|
1982-01-22 |
1983-07-30 |
フアイソンズ・ピ−エルシ− |
薬学的組成物
|
|
JPS58222014A
(ja)
*
|
1982-06-18 |
1983-12-23 |
Taisho Pharmaceut Co Ltd |
プロスタグランジンｅ↓１脂肪乳剤
|
|
US4588578A
(en)
*
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
|
GB8322178D0
(en)
*
|
1983-08-17 |
1983-09-21 |
Sterwin Ag |
Preparing aerosol compositions
|
|
US4744989A
(en)
*
|
1984-02-08 |
1988-05-17 |
E. R. Squibb & Sons, Inc. |
Method of preparing liposomes and products produced thereby
|
|
US5141674A
(en)
*
|
1984-03-08 |
1992-08-25 |
Phares Pharmaceutical Research N.V. |
Methods of preparing pro-liposome dispersions and aerosols
|
|
JPS60208910A
(ja)
*
|
1984-03-31 |
1985-10-21 |
Green Cross Corp:The |
水難溶性薬物・リン脂質複合体の製造方法
|
|
SE8403905D0
(sv)
*
|
1984-07-30 |
1984-07-30 |
Draco Ab |
Liposomes and steroid esters
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
US5077056A
(en)
*
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
EP0172007B1
(en)
*
|
1984-08-10 |
1991-05-22 |
Syntex (U.S.A.) Inc. |
Stable liposomes with aqueous-soluble medicaments and methods for their preparation
|
|
JPS6150912A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Shionogi & Co Ltd |
リポソ−ム製剤の製造法
|
|
JPS61100518A
(ja)
*
|
1984-10-22 |
1986-05-19 |
Ono Pharmaceut Co Ltd |
ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4830858A
(en)
*
|
1985-02-11 |
1989-05-16 |
E. R. Squibb & Sons, Inc. |
Spray-drying method for preparing liposomes and products produced thereby
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
FR2591105B1
(fr)
*
|
1985-12-11 |
1989-03-24 |
Moet Hennessy Rech |
Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
|
|
US5068198A
(en)
*
|
1986-03-26 |
1991-11-26 |
Syntex (U.S.A.) Inc. |
Liquid single reagent for assays involving confining gels
|
|
SE8601457D0
(sv)
*
|
1986-04-01 |
1986-04-01 |
Draco Ab |
Compositions of liposomes and b?712-receptor active substances for inhalation
|
|
FR2597345B1
(fr)
*
|
1986-04-22 |
1990-08-03 |
Oreal |
Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
|
|
SE8603812D0
(sv)
*
|
1986-09-12 |
1986-09-12 |
Draco Ab |
Administration of liposomes to mammals
|
|
US4891324A
(en)
*
|
1987-01-07 |
1990-01-02 |
Syntex (U.S.A.) Inc. |
Particle with luminescer for assays
|
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
|
WO1988009170A1
(en)
*
|
1987-05-22 |
1988-12-01 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
|
US5178875A
(en)
*
|
1991-01-14 |
1993-01-12 |
The Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
|
US5830498A
(en)
*
|
1987-10-16 |
1998-11-03 |
Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US4981690A
(en)
*
|
1987-10-27 |
1991-01-01 |
Board Of Regents, The University Of Texas System |
Liposome-incorporated mepartricin
|
|
JPH0610131B2
(ja)
*
|
1987-10-30 |
1994-02-09 |
テルモ株式会社 |
リポソームの製法
|
|
EP0397774A1
(en)
*
|
1988-02-04 |
1990-11-22 |
Board Of Regents, The University Of Texas System |
Formulation and use of retinoids in treatment of cancer and other diseases
|
|
US5096629A
(en)
*
|
1988-08-29 |
1992-03-17 |
501 Nippon Fine Chemical Co., Ltd. |
Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
|
|
EP0440742B1
(en)
*
|
1988-10-27 |
1997-01-15 |
The Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
|
US5174988A
(en)
*
|
1989-07-27 |
1992-12-29 |
Scientific Development & Research, Inc. |
Phospholipid delivery system
|
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
IN172208B
(US06272168-20010807-M00014.png)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
JP3533215B2
(ja)
*
|
1990-07-31 |
2004-05-31 |
ザ リポソーム カンパニー，インコーポレイテッド |
アミノ酸及びペプチドのリポソーム内への蓄積
|
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
|
US5340716A
(en)
*
|
1991-06-20 |
1994-08-23 |
Snytex (U.S.A.) Inc. |
Assay method utilizing photoactivated chemiluminescent label
|
|
US5885260A
(en)
*
|
1991-05-30 |
1999-03-23 |
Mehl, Sr.; Thomas L. |
Freeze-dried liposome delivery system for application of skin treatment agents
|
|
ATE243997T1
(de)
*
|
1991-06-18 |
2003-07-15 |
Imarx Pharmaceutical Corp |
Neue liposomale arzneimittelfreisetzungssysteme
|
|
FR2681781A1
(fr)
|
1991-09-30 |
1993-04-02 |
Oreal |
Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
|
|
AU3423493A
(en)
*
|
1991-12-31 |
1993-07-28 |
Zymogenetics Inc. |
Methods and compositions for reducing blood loss
|
|
IL104084A
(en)
*
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
|
USRE37224E1
(en)
*
|
1992-06-05 |
2001-06-12 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
|
|
US5736141A
(en)
*
|
1992-06-05 |
1998-04-07 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
|
|
CA2141451C
(en)
*
|
1992-07-31 |
2003-10-07 |
John S. Pease |
Photoactivatable chemiluminescent matrices
|
|
DE4309579C3
(de)
*
|
1993-03-24 |
2000-01-27 |
Sanol Arznei Schwarz Gmbh |
Pharmazeutische Zusammensetzung in Form einer Packung
|
|
DK0678017T3
(da)
|
1993-11-05 |
1998-10-19 |
Amgen Inc |
Liposomfremstilling og materialeindkapslingsfremgangsmåde
|
|
ATE234638T1
(de)
*
|
1993-12-15 |
2003-04-15 |
Bracco Research Sa |
Gas-mischungen verwendbar als ultraschallkontrastmittel
|
|
IT1269569B
(it)
*
|
1994-04-22 |
1997-04-08 |
Ugo Citernesi |
Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
|
|
US6156337A
(en)
*
|
1994-07-08 |
2000-12-05 |
Opperbas Holding B.V. |
Method for high loading of vesicles with biopolymeric substances
|
|
IL115099A
(en)
*
|
1994-10-14 |
1999-04-11 |
Upjohn Co |
Lyophilizate of phospholipid complex of water insoluble camptothecins
|
|
US5834428A
(en)
*
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US5990077A
(en)
|
1995-04-14 |
1999-11-23 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
US5902604A
(en)
*
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
DE69716905T2
(de)
|
1996-04-12 |
2003-07-24 |
1149336 Ontario Inc., Toronto |
Analoge des glucagon ähnlichen peptides -2
|
|
US6111081A
(en)
*
|
1996-05-31 |
2000-08-29 |
Baylor College Of Medicine |
Lactoferrin variants and uses thereof
|
|
DE69710599T2
(de)
*
|
1996-10-25 |
2003-03-06 |
Monsanto Technology Llc., St. Louis |
Zusammensetzung und verfahren zur behandlung von pflanzen mit exogenen chemikalien
|
|
CA2269592C
(en)
|
1996-10-25 |
2008-05-20 |
Monsanto Company |
Composition and method for treating plants with exogenous chemicals
|
|
US6037125A
(en)
*
|
1996-11-05 |
2000-03-14 |
Lexicon Genetics Incorporated |
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
|
|
CA2236519C
(en)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
|
NZ525552A
(en)
*
|
2000-11-09 |
2005-04-29 |
Neopharm Inc |
SN-38 lipid complexes with cardiolipin and methods of use for the treatment of cancers and multiple sclerosis
|
|
AU3169702A
(en)
*
|
2000-12-07 |
2002-06-18 |
Yamanouchi Europ Bv |
Composition for treatment of inflammatory disorders
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
US6939564B2
(en)
*
|
2001-06-08 |
2005-09-06 |
Labopharm, Inc. |
Water-soluble stabilized self-assembled polyelectrolytes
|
|
US6780324B2
(en)
*
|
2002-03-18 |
2004-08-24 |
Labopharm, Inc. |
Preparation of sterile stabilized nanodispersions
|
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
|
US20060093661A1
(en)
|
2002-05-07 |
2006-05-04 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
US20030212046A1
(en)
*
|
2002-05-07 |
2003-11-13 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
|
DE102005017777A1
(de)
*
|
2005-04-13 |
2006-10-19 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen
|
|
DE502006005846D1
(de)
|
2005-04-13 |
2010-02-25 |
Abbott Gmbh & Co Kg |
Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
|
|
WO2008035229A2
(en)
*
|
2006-09-22 |
2008-03-27 |
Labopharm, Inc. |
Compositions and methods for ph targeted drug delivery
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
EP2555791B1
(en)
|
2010-04-09 |
2017-11-01 |
Sinai Health System |
Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
|
|
WO2012094033A1
(en)
|
2011-01-05 |
2012-07-12 |
Livon Laboratories |
Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
|
|
ES2913946T3
(es)
|
2013-07-08 |
2022-06-06 |
The Univ Of Utah Research Foundation |
Péptido y su uso en el tratamiento de trastornos inflamatorios
|
|
US10772926B2
(en)
|
2016-12-16 |
2020-09-15 |
Nutragen Health Innovations, Inc. |
Natural drugs for the treatment of inflammation and melanoma
|
|
WO2018204918A1
(en)
|
2017-05-05 |
2018-11-08 |
Ardelyx, Inc. |
Treatment of hepatic disorders
|
|
JP2021518401A
(ja)
|
2018-03-21 |
2021-08-02 |
コロラド ステート ユニバーシティー リサーチ ファウンデーション |
がんワクチン組成物及びその使用方法
|
|
RU2740553C2
(ru)
*
|
2019-01-30 |
2021-01-15 |
Анастасия Андреевна Карбаинова |
Способ получения липосомальной формы бетулина, обладающей гепатопротекторной активностью
|
|
LT6699B
(lt)
|
2019-07-15 |
2020-02-10 |
UAB "Valentis" |
Proliposomų gamybos būdas, naudojant ne daugiau kaip 5 % etanolio, ir jų panaudojimas lipofilinių medžiagų kapsuliavimui
|
|
US20230346915A1
(en)
|
2020-03-06 |
2023-11-02 |
Colorado State University Research Foundation |
Production Of Vaccines Comprising Inactivated SARS-COV-2 Viral Particles
|
|
IL300113A
(en)
|
2020-07-28 |
2023-03-01 |
Jazz Pharmaceuticals Ireland Ltd |
Compressed cyclic RAF inhibitors and methods of using them
|
|
MX2023001274A
(es)
|
2020-07-28 |
2023-04-24 |
Jazz Pharmaceuticals Ireland Ltd |
Sintesis quiral de inhibidores de raf biciclicos fusionados.
|
|
WO2022212863A1
(en)
|
2021-04-01 |
2022-10-06 |
Vestaron Corporation |
Liposome formulations for pesticide delivery and methods for producing and using the same
|
|
CN118488834A
(zh)
|
2021-11-23 |
2024-08-13 |
赛欧生物医药股份有限公司 |
细菌源性脂质组合物和其用途
|
|
WO2024159172A1
(en)
|
2023-01-27 |
2024-08-02 |
Senda Biosciences, Inc. |
A modified lipid composition and uses thereof
|
